That is why the combination is often used when the biggest complaints are poor sleep, slower recovery, reduced resilience, and difficulty maintaining performance under stress
Disclosure of interest: Pier Andrea Rizzo: nothing to disclose Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P1074 - ESOC25-2189 ACTIVATED LEUCOCYTE CELL ADHESION MOLECULE IN MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION Alejandro Rodrguez Vzquez 1,2,3 , Andrea Cabero-Arnold 1,2 , Carlos Laredo 1,2 , Monica Serrano 1 , Yolanda Gonzlez Romero 1 , Antonio Doncel-Moriano 1 , Salvatore Rudilosso, Sergio Amaro, Arturo Ren 1 , Laura Llull, Angel Chamorro 1 , Francisco Lozano 2,4 , Xabier Urra 1 1 Comprehensive Stroke Center, Hospital Clnic de Barcelona, Barcelona, Spain, 2 Fundaci de Recerca Clnic Barcelona - Institut d'Investigacins Biomdiques August Pi i Sunyer, Barcelona, Spain, 3 Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain, 4 Centre de Diagnstic Biomdic, Hospital Clnic de Barcelona, Barcelona, Spain Background and Aims: Malignant cerebral infarction (MCI) is a devastating situation with no effective treatment besides hemicraniectomy
Summary: Adults with B12 deficiency and nerve pain typically require 1 mg hydroxocobalamin injections intramuscularly on alternate days until symptoms improve, followed by maintenance injections every two months
The efficacy and safety of Mirvetuximab Soravtansine in FR-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
